CLBT · NASDAQ · Software - Infrastructure

Cellebrite DI (CLBT)

Software for accessing, analyzing, and managing evidence across legally sanctioned digital investigations.

$11.58
vs last close−0.09 (−0.73%)
Loading prices…

Cellebrite DI Ltd.CLBT
Information Technology

Supplies subscription software and services that access, decode, analyze, share, and manage digital evidence for legally sanctioned investigations. Its portfolio serves public-safety agencies, defense and intelligence organizations, and enterprises worldwide, with public-sector customers generating most revenue.

Provides software and services for legally sanctioned digital investigations. Inseyets accesses, extracts, and decodes evidence from phones, computers, cloud applications, vehicles, and other sources; Guardian manages evidence and case workflows, while Pathfinder and Genesis apply analytics and AI to surface connections and source-traced findings.

Corellium adds Arm-device virtualization for vulnerability research, malware analysis, and mobile-application testing; portable tools collect and decode UAV data. Cloud, on-premise, and hybrid offerings generate revenue through term licenses, SaaS subscriptions, maintenance, support, training, and advanced forensic services.

Maintains broad device and operating-system coverage through mobile research. Serves customers across the Americas, Europe, the Middle East and Africa, and Asia-Pacific, while public-sector agencies generate most revenue. Results depend on government procurement cycles, device-security changes, Israeli export controls, privacy rules, and lawful customer use.

Company facts

CEOShiven Ramji
ListedAug 31, 2021
ExchangeNASDAQ
HeadquartersPetah Tikva, Israel
CountryIsrael
Employees1,285
CIK0001854587
ISINIL0011794802

Market cap$2.91B
EPS (ttm)$0.2339
P/E (ttm)49.85
ROE11.9%
P/B5.41
P/S5.66
Dividend yieldDiv yield
Beta0.65vs XLK 0.14

Price target$14.50+24.4%Average of 9 analysts
ConsensusBuy9 of 9 analysts
Ratings

Target rangeAs of Sep 22, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 14, 2026DA DavidsonReiterate
Rating: Target: $22
Rating: BuyTarget: $15
Aug 14, 2026Lake StreetReiterate
Rating: Target: $21
Rating: BuyTarget: $15
Aug 14, 2026Deutsche BankTarget
Target:
Target: $14
Aug 14, 2026NeedhamReiterate
Rating: Target: $15
Rating: BuyTarget: $12.50
Aug 6, 2026DA DavidsonReiterate
Rating: Target: $20
Rating: BuyTarget: $22

Next report
Nov 11, 26
in 49 days
EPS estimate
$0.17
Revenue estimate
$145.9M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.10$0.10$0.12$0.08$0.09$0.04$0.03Pending
Estimate$0.10$0.05$0.10$0.09$0.14$0.05$0.06$0.17
Surprise0.0%+90.3%+20.0%−15.3%−38.1%−25.6%−56.7%

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$109.0M$107.5M$113.3M$126.0M$128.8M$128.3M$131.1MPending
Estimate$107.3M$109.3M$112.3M$123.0M$126.1M$127.0M$131.5M$145.9M
Surprise+1.7%−1.6%+0.8%+2.5%+2.1%+1.0%−0.3%
Estimate$0.17
ReportedDue Nov 11, 2026
Estimate$145.9M
ReportedDue Nov 11, 2026
View details

Debt to equity4.30%
Current ratio160.10%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$106.9M$109.0M$107.5M$113.3M$126.0M$128.8M$128.3M$131.1M
Net income−$207.1M$19.3M$17.4M$19.5M$20.2M$21.3M$10.9M$6.4M
Net margin0.0%17.7%16.2%17.2%16.0%16.5%8.5%4.9%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$19.4M$15.7M$12.3M$14.4M$19.0M$20.8M$9.1M$7.6M
YoY growth+44.3%+4.9%+32.7%+15.5%−2.3%+32.3%−25.7%−47.1%

Balance sheet, Jun 30, 2026Cash & short-term investments $442.5M · Total debt $23.2M · Total assets $994.3M · Shareholders' equity $538.1M

Revenue
$131.1M
Operating income
$7.6M
Net income
$6.4M
View details

No dividends on record.

Institutions50.32%125.51M ADS
214 holders · as of Jun 30, 2026
Insiders43.99%109.72M ADS
19 holders · as of Sep 17, 2026
Other5.69%14.21M ADS
remainder

249.44M ADS as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
SuncorporationInsider
42.52%106.07Mfiled Feb 24, 2026
True Wind Capital Management, L.P.Institution
5.56%13.86M ADSas of Jun 30, 2026
Voss Capital, LLCInstitution
4.59%11.44M ADSas of Jun 30, 2026
Pertento Partners LLPInstitution
3.21%8.00M ADSas of Jun 30, 2026
Phoenix Holdings Ltd.Institution
2.48%6.18M ADSas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Aug 25, 2026Thomas E. Hoganother: Advisor−25,299$11.29
Aug 24, 2026David Nicholas Geeofficer: Chief Marketing Officer−4,323$11.36
Aug 21, 2026David Nicholas Geeofficer: Chief Marketing Officer−2,198$11.24
Aug 21, 2026Marcus Jewellofficer: Global Chief Revenue Officer−12,562$11.24
Aug 12, 2026Thomas E. Hogandirector, officer: Chief Executive Officer−139,713$15.39
View details

  • Nexalin Technology

    Investigative analytics for large, complex digital-data collections

  • OpenText

    Court-ready endpoint and mobile digital forensics

  • NiCE (ADR)

    Digital-evidence management for justice agencies

Compare

CompanyPriceChange
Cellebrite DI$11.58−0.73%$2.91B49.928.75.7+15.8%
Nexalin Technology$4.86+4.94%$3.4M15.6−82.8%
OpenText$23.11+0.50%$5.58B5.15.90.6+0.6%
NiCE (ADR)$116.94−1.14%$6.93B17.19.82.2+7.7%
Median11.17.92.2+0.6%